SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
SIGNAL TRANSDUCTION BY IGM IN B LYMPHOCYTES
批准号:
6373315
负责人:
Michel C Nussenzweig
金额:
$19.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 2003-04-30
关键词:
B cell receptor B lymphocyte biological signal transduction cell differentiation chimeric proteins gene mutation gene rearrangement immunoglobulin M immunoglobulin genes laboratory mouse leukocyte activation /transformation protein structure receptor expression site directed mutagenesis tissue /cell culture
中文摘要
描述(改编自研究人员摘要):B细胞抗原
受体(BCR)调节许多不同的重要生理过程
在抗体系统中。这些生理反应可以分为两种
类别,不依赖于抗原的类别和诱导的类别
通过抗原。在这笔赠款的第一个资助期内,我们定义了
MIgM和IGA-IGB信号转导之间的基本相互作用。
这一信息随后被用来表明抗原非依赖性事件
包括由膜调节几个不同的转换
免疫球蛋白(MIgm)通过免疫球蛋白-免疫球蛋白信号转导。尽管它
了解与抗原结合是如何使mIgM交联并激活的
IgA-Igb信号转导,mIgM的分子机制
被触发以诱导抗原非依赖性事件的机制仍有待阐明。
在了解抗原非依赖性事件如何被激活方面取得了进展
由于缺乏对交联剂性质的了解而受到阻碍,
可识别的BCR的结构特征,以及是否
新生的mIgM需要在细胞表面表达才能触发这些
回应。拟议研究的长期目标是阐明
激活等位基因排斥和前B细胞的分子机制
过渡。该项目的第一部分将审查结构
B细胞发育所需免疫球蛋白和免疫球蛋白的特性及B细胞应答
与抗原有关。该项目的第二部分将尝试确定
发育中B细胞对mIgM信号的细胞和分子需求
细胞。该项目的第三部分旨在尝试定义
MIgM表达与等位基因排斥的关系这些研究
对了解B细胞是如何发育和
在体内产生免疫反应。
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): B cell antigen
receptors (BCR) regulate many different physiologically important processes
in the antibody system. These physiologic responses can be divided into two
categories, those which are antigen independent and those which are induced
by antigen. During the first funding period for this grant we have defined
essential interactions between mIgM and the Iga-Igb signal transducers.
This information was then used to show that the antigen independent events
include several distinct transitions that are regulated by membrane
immunoglobulin (mIgm) through the Iga-Igb signal transducers. Although it
is understood how binding to antigen might crosslink mIgM and activate
Iga-Igb signal transducers, the molecular mechanisms by which mIgM is
triggered to induce antigen independent events remain to be elucidated.
Progress in understanding how antigen independent events are activated has
been hindered by a lack of understanding of the nature of the crosslinker,
the structural features of the BCR that are recognized, and whether the
nascent mIgM needs to be expressed on the cell surface to trigger these
responses. The long range goal of the proposed research is to elucidate the
molecular mechanisms that activate allelic exclusion and the pre-B cell
transition. The first part of the project will examine the structural
features of Iga and Igb required for B cell development and B cell responses
to antigen. The second part of the project will be to try to determine the
cellular and molecular requirements for mIgM signaling in developing B
cells. The third part of the project will aim to try to define the
relationship between mIgM expression and allelic exclusion. These studies
have potential implications for understanding how B cells develop and
produce immune responses in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10841240
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
-
批准号:10327992
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10221136
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10221139
-
项目类别:
-
资助金额:$81.67万
-
财政年份:2020
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10546453
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:9546037
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Class Switch Recombination in B Lymphocytes
-
批准号:10331863
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10454947
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10454946
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:9982204
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
-
批准号:10265634
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10540735
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10300443
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10454949
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:9569038
-
项目类别:
-
资助金额:$136.51万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Activation of HIV-1 specific B cell precursors using novel vaccine approaches
-
批准号:10062819
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:9982202
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Admin Core
-
批准号:10216965
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Epitope-focused vaccine strategies against Zika virus
-
批准号:10216964
-
项目类别:
-
资助金额:$134.78万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
Project 1
-
批准号:10216967
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2018
-
负责人:Michel C Nussenzweig
-
依托单位:
海外基金